PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-11-10

Date Title Company
10-Nov-2025 CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 ACCESS Newswire
10-Nov-2025 FACT's New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients ACCESS Newswire
10-Nov-2025 eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST ACCESS Newswire
10-Nov-2025 CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ ACCESS Newswire
10-Nov-2025 The National Children's Cancer Society (NCCS) Announces New Mission and Vision Statements Reflecting Its Continued Commitment to Families Impacted by Childhood Cancer ACCESS Newswire
10-Nov-2025 Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 ACCESS Newswire
10-Nov-2025 Reporting Of Transactions Made By Persons Discharging Managerial Responsibilities And Persons Closely Associated With Them In Gubra A/S' Shares ACCESS Newswire
10-Nov-2025 More early breast cancer patients, at high risk of recurrence, gain access to Novartis’ Kisqali® (ribociclib) as the treatment is accepted for use in Scotland Novartis Pharmaceuticals UK Ltd
10-Nov-2025 Federal Marijuana Crackdown Confirms the Future: DEA's Obstruction of MMJ Science Exposed as Congress Moves to Re-Criminalize the $30 Billion THC Gray Market ACCESS Newswire
10-Nov-2025 Brainomix Recognized in Global Health Tech Competition for Its Innovative Brainomix 360 Stroke Technology Brainomix
10-Nov-2025 The National Children's Cancer Society Awards 50 Scholarships to Childhood Cancer Survivors Nationwide ACCESS Newswire
10-Nov-2025 Desert Oasis Healthcare Expands Maternal Health Resources with New Maternal Health Educator Position and Updated Video Education Series ACCESS Newswire
10-Nov-2025 Brain Balance Expands to Brooklyn, New York, Led by Veteran Educator and Advocate Sarah Weeks ACCESS Newswire
10-Nov-2025 Reporting of Transactions Made by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them in Gubra A/S' Shares ACCESS Newswire
10-Nov-2025 Athos Therapeutics and Xeptiva Therapeutics Announce Partnership to Discover Vaccine Biomarkers with the AthosOmics.AI Platform ACCESS Newswire
10-Nov-2025 Amniotic Products Market Overview 2025 | Regional Overview, Analysis, and Future Outlook Medi-Tech Insights
10-Nov-2025 Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers Nouscom
10-Nov-2025 Resolution Therapeutics announces new data showcasing the potential of Regenerative Macrophage Therapy in treating cirrhosis at AASLD 2025 Resolution Therapeutics
10-Nov-2025 ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review ACAAI
10-Nov-2025 Leucid Bio Provides Update on Phase I/IIa AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumours Leucid Bio